nodes	percent_of_prediction	percent_of_DWPC	metapath
Acitretin—ALB—melanoma	0.33	1	CbGaD
Acitretin—ALB—Vemurafenib—melanoma	0.0322	1	CbGbCtD
Acitretin—RBP1—optic choroid—melanoma	0.023	0.252	CbGeAlD
Acitretin—RBP1—hair follicle—melanoma	0.00927	0.102	CbGeAlD
Acitretin—RXRG—neck—melanoma	0.00562	0.0616	CbGeAlD
Acitretin—RBP1—eye—melanoma	0.00463	0.0507	CbGeAlD
Acitretin—RBP1—retina—melanoma	0.00458	0.0502	CbGeAlD
Acitretin—RXRG—eye—melanoma	0.00418	0.0458	CbGeAlD
Acitretin—RBP1—skin of body—melanoma	0.00402	0.0441	CbGeAlD
Acitretin—RARG—eye—melanoma	0.00349	0.0383	CbGeAlD
Acitretin—RARG—retina—melanoma	0.00346	0.0379	CbGeAlD
Acitretin—RARG—skin of body—melanoma	0.00304	0.0333	CbGeAlD
Acitretin—RARG—mammalian vulva—melanoma	0.00277	0.0304	CbGeAlD
Acitretin—RXRA—head—melanoma	0.0027	0.0296	CbGeAlD
Acitretin—RBP1—head—melanoma	0.00263	0.0288	CbGeAlD
Acitretin—RARB—head—melanoma	0.00243	0.0266	CbGeAlD
Acitretin—RXRG—head—melanoma	0.00237	0.026	CbGeAlD
Acitretin—RXRB—head—melanoma	0.00223	0.0245	CbGeAlD
Acitretin—RARG—head—melanoma	0.00198	0.0217	CbGeAlD
Acitretin—RARA—head—melanoma	0.00186	0.0204	CbGeAlD
Acitretin—RBP1—lymph node—melanoma	0.00184	0.0202	CbGeAlD
Acitretin—RARB—lymph node—melanoma	0.0017	0.0186	CbGeAlD
Acitretin—RARG—lymph node—melanoma	0.00139	0.0152	CbGeAlD
Acitretin—RARA—lymph node—melanoma	0.0013	0.0143	CbGeAlD
Acitretin—ALB—lymph node—melanoma	0.000736	0.00806	CbGeAlD
Acitretin—Stomatitis—Dactinomycin—melanoma	0.000607	0.00218	CcSEcCtD
Acitretin—Gastrointestinal disorder—Vemurafenib—melanoma	0.000607	0.00218	CcSEcCtD
Acitretin—Fatigue—Vemurafenib—melanoma	0.000606	0.00217	CcSEcCtD
Acitretin—Haemoglobin—Bleomycin—melanoma	0.000603	0.00216	CcSEcCtD
Acitretin—Constipation—Vemurafenib—melanoma	0.000601	0.00215	CcSEcCtD
Acitretin—Pancytopenia—Temozolomide—melanoma	0.0006	0.00215	CcSEcCtD
Acitretin—Haemorrhage—Bleomycin—melanoma	0.0006	0.00215	CcSEcCtD
Acitretin—Hypoaesthesia—Bleomycin—melanoma	0.000597	0.00214	CcSEcCtD
Acitretin—Dysuria—Temozolomide—melanoma	0.000591	0.00212	CcSEcCtD
Acitretin—Erectile dysfunction—Temozolomide—melanoma	0.000582	0.00209	CcSEcCtD
Acitretin—Depression—Carmustine—melanoma	0.000581	0.00208	CcSEcCtD
Acitretin—Photosensitivity reaction—Temozolomide—melanoma	0.000577	0.00207	CcSEcCtD
Acitretin—Weight increased—Temozolomide—melanoma	0.000575	0.00206	CcSEcCtD
Acitretin—Weight decreased—Temozolomide—melanoma	0.000572	0.00205	CcSEcCtD
Acitretin—Neuropathy peripheral—Carmustine—melanoma	0.000572	0.00205	CcSEcCtD
Acitretin—Stomatitis—Carmustine—melanoma	0.000568	0.00204	CcSEcCtD
Acitretin—Urinary tract infection—Carmustine—melanoma	0.000567	0.00203	CcSEcCtD
Acitretin—Depression—Temozolomide—melanoma	0.000562	0.00201	CcSEcCtD
Acitretin—Hepatitis—Dactinomycin—melanoma	0.000559	0.002	CcSEcCtD
Acitretin—Flushing—Bleomycin—melanoma	0.000557	0.00199	CcSEcCtD
Acitretin—Body temperature increased—Vemurafenib—melanoma	0.000556	0.00199	CcSEcCtD
Acitretin—Pharyngitis—Dactinomycin—melanoma	0.000555	0.00199	CcSEcCtD
Acitretin—Neuropathy peripheral—Temozolomide—melanoma	0.000552	0.00198	CcSEcCtD
Acitretin—Stomatitis—Temozolomide—melanoma	0.000549	0.00197	CcSEcCtD
Acitretin—Urinary tract infection—Temozolomide—melanoma	0.000548	0.00196	CcSEcCtD
Acitretin—Deafness—Docetaxel—melanoma	0.000544	0.00195	CcSEcCtD
Acitretin—Chills—Bleomycin—melanoma	0.000538	0.00193	CcSEcCtD
Acitretin—Alopecia—Bleomycin—melanoma	0.00053	0.0019	CcSEcCtD
Acitretin—Sinusitis—Temozolomide—melanoma	0.000529	0.00189	CcSEcCtD
Acitretin—Haemoglobin—Carmustine—melanoma	0.000526	0.00189	CcSEcCtD
Acitretin—Haemorrhage—Carmustine—melanoma	0.000523	0.00188	CcSEcCtD
Acitretin—Erythema—Bleomycin—melanoma	0.000522	0.00187	CcSEcCtD
Acitretin—Hypoaesthesia—Carmustine—melanoma	0.000521	0.00187	CcSEcCtD
Acitretin—Hot flush—Docetaxel—melanoma	0.00052	0.00186	CcSEcCtD
Acitretin—Flushing—Dactinomycin—melanoma	0.000519	0.00186	CcSEcCtD
Acitretin—Hypersensitivity—Vemurafenib—melanoma	0.000518	0.00186	CcSEcCtD
Acitretin—Oedema peripheral—Carmustine—melanoma	0.000516	0.00185	CcSEcCtD
Acitretin—Menopausal symptoms—Docetaxel—melanoma	0.000515	0.00185	CcSEcCtD
Acitretin—Visual disturbance—Docetaxel—melanoma	0.000513	0.00184	CcSEcCtD
Acitretin—Dermatitis bullous—Docetaxel—melanoma	0.000509	0.00182	CcSEcCtD
Acitretin—Haemoglobin—Temozolomide—melanoma	0.000508	0.00182	CcSEcCtD
Acitretin—Hepatitis—Temozolomide—melanoma	0.000506	0.00181	CcSEcCtD
Acitretin—Haemorrhage—Temozolomide—melanoma	0.000506	0.00181	CcSEcCtD
Acitretin—Asthenia—Vemurafenib—melanoma	0.000505	0.00181	CcSEcCtD
Acitretin—Visual impairment—Carmustine—melanoma	0.000504	0.00181	CcSEcCtD
Acitretin—Hypoaesthesia—Temozolomide—melanoma	0.000503	0.0018	CcSEcCtD
Acitretin—Pharyngitis—Temozolomide—melanoma	0.000502	0.0018	CcSEcCtD
Acitretin—Chills—Dactinomycin—melanoma	0.000502	0.0018	CcSEcCtD
Acitretin—Oedema peripheral—Temozolomide—melanoma	0.000498	0.00179	CcSEcCtD
Acitretin—Pruritus—Vemurafenib—melanoma	0.000498	0.00178	CcSEcCtD
Acitretin—Alopecia—Dactinomycin—melanoma	0.000494	0.00177	CcSEcCtD
Acitretin—Eye disorder—Carmustine—melanoma	0.000489	0.00175	CcSEcCtD
Acitretin—Visual impairment—Temozolomide—melanoma	0.000487	0.00175	CcSEcCtD
Acitretin—Erythema—Dactinomycin—melanoma	0.000487	0.00174	CcSEcCtD
Acitretin—Flushing—Carmustine—melanoma	0.000486	0.00174	CcSEcCtD
Acitretin—Ill-defined disorder—Bleomycin—melanoma	0.000484	0.00174	CcSEcCtD
Acitretin—Diarrhoea—Vemurafenib—melanoma	0.000481	0.00172	CcSEcCtD
Acitretin—Migraine—Docetaxel—melanoma	0.000479	0.00171	CcSEcCtD
Acitretin—Eye disorder—Temozolomide—melanoma	0.000473	0.00169	CcSEcCtD
Acitretin—Tinnitus—Temozolomide—melanoma	0.000472	0.00169	CcSEcCtD
Acitretin—Malaise—Bleomycin—melanoma	0.000471	0.00169	CcSEcCtD
Acitretin—Flushing—Temozolomide—melanoma	0.000469	0.00168	CcSEcCtD
Acitretin—Dizziness—Vemurafenib—melanoma	0.000465	0.00167	CcSEcCtD
Acitretin—Alopecia—Carmustine—melanoma	0.000463	0.00166	CcSEcCtD
Acitretin—Angiopathy—Temozolomide—melanoma	0.000459	0.00164	CcSEcCtD
Acitretin—Immune system disorder—Temozolomide—melanoma	0.000457	0.00164	CcSEcCtD
Acitretin—Erythema—Carmustine—melanoma	0.000456	0.00163	CcSEcCtD
Acitretin—Cough—Bleomycin—melanoma	0.000456	0.00163	CcSEcCtD
Acitretin—Chills—Temozolomide—melanoma	0.000454	0.00163	CcSEcCtD
Acitretin—Ill-defined disorder—Dactinomycin—melanoma	0.000452	0.00162	CcSEcCtD
Acitretin—Liver function test abnormal—Docetaxel—melanoma	0.000449	0.00161	CcSEcCtD
Acitretin—Vomiting—Vemurafenib—melanoma	0.000447	0.0016	CcSEcCtD
Acitretin—Alopecia—Temozolomide—melanoma	0.000447	0.0016	CcSEcCtD
Acitretin—Dry skin—Docetaxel—melanoma	0.000446	0.0016	CcSEcCtD
Acitretin—Chest pain—Bleomycin—melanoma	0.000444	0.00159	CcSEcCtD
Acitretin—Myalgia—Bleomycin—melanoma	0.000444	0.00159	CcSEcCtD
Acitretin—Rash—Vemurafenib—melanoma	0.000443	0.00159	CcSEcCtD
Acitretin—Dermatitis—Vemurafenib—melanoma	0.000443	0.00159	CcSEcCtD
Acitretin—Back pain—Carmustine—melanoma	0.000441	0.00158	CcSEcCtD
Acitretin—Headache—Vemurafenib—melanoma	0.000441	0.00158	CcSEcCtD
Acitretin—Erythema—Temozolomide—melanoma	0.00044	0.00158	CcSEcCtD
Acitretin—Discomfort—Bleomycin—melanoma	0.000439	0.00157	CcSEcCtD
Acitretin—Malaise—Dactinomycin—melanoma	0.000439	0.00157	CcSEcCtD
Acitretin—Dysgeusia—Temozolomide—melanoma	0.000431	0.00155	CcSEcCtD
Acitretin—Vision blurred—Carmustine—melanoma	0.000429	0.00154	CcSEcCtD
Acitretin—Alanine aminotransferase increased—Docetaxel—melanoma	0.000429	0.00154	CcSEcCtD
Acitretin—Oedema—Bleomycin—melanoma	0.000426	0.00153	CcSEcCtD
Acitretin—Back pain—Temozolomide—melanoma	0.000426	0.00153	CcSEcCtD
Acitretin—Infection—Bleomycin—melanoma	0.000423	0.00152	CcSEcCtD
Acitretin—Nausea—Vemurafenib—melanoma	0.000418	0.0015	CcSEcCtD
Acitretin—Vision blurred—Temozolomide—melanoma	0.000415	0.00149	CcSEcCtD
Acitretin—Myalgia—Dactinomycin—melanoma	0.000414	0.00149	CcSEcCtD
Acitretin—Discomfort—Dactinomycin—melanoma	0.00041	0.00147	CcSEcCtD
Acitretin—Ill-defined disorder—Temozolomide—melanoma	0.000409	0.00146	CcSEcCtD
Acitretin—Anorexia—Bleomycin—melanoma	0.000406	0.00146	CcSEcCtD
Acitretin—Angioedema—Temozolomide—melanoma	0.000402	0.00144	CcSEcCtD
Acitretin—Pancytopenia—Docetaxel—melanoma	0.000399	0.00143	CcSEcCtD
Acitretin—Oedema—Dactinomycin—melanoma	0.000397	0.00142	CcSEcCtD
Acitretin—Malaise—Temozolomide—melanoma	0.000397	0.00142	CcSEcCtD
Acitretin—Infection—Dactinomycin—melanoma	0.000395	0.00141	CcSEcCtD
Acitretin—Musculoskeletal discomfort—Bleomycin—melanoma	0.000388	0.00139	CcSEcCtD
Acitretin—Chest pain—Carmustine—melanoma	0.000388	0.00139	CcSEcCtD
Acitretin—Myalgia—Carmustine—melanoma	0.000388	0.00139	CcSEcCtD
Acitretin—Anxiety—Carmustine—melanoma	0.000387	0.00139	CcSEcCtD
Acitretin—Cough—Temozolomide—melanoma	0.000384	0.00138	CcSEcCtD
Acitretin—Paraesthesia—Bleomycin—melanoma	0.000383	0.00137	CcSEcCtD
Acitretin—Weight increased—Docetaxel—melanoma	0.000382	0.00137	CcSEcCtD
Acitretin—Weight decreased—Docetaxel—melanoma	0.00038	0.00136	CcSEcCtD
Acitretin—Anorexia—Dactinomycin—melanoma	0.000379	0.00136	CcSEcCtD
Acitretin—Arthralgia—Temozolomide—melanoma	0.000375	0.00134	CcSEcCtD
Acitretin—Myalgia—Temozolomide—melanoma	0.000375	0.00134	CcSEcCtD
Acitretin—Anxiety—Temozolomide—melanoma	0.000374	0.00134	CcSEcCtD
Acitretin—Oedema—Carmustine—melanoma	0.000372	0.00133	CcSEcCtD
Acitretin—Discomfort—Temozolomide—melanoma	0.00037	0.00133	CcSEcCtD
Acitretin—Decreased appetite—Bleomycin—melanoma	0.00037	0.00133	CcSEcCtD
Acitretin—Infection—Carmustine—melanoma	0.000369	0.00132	CcSEcCtD
Acitretin—Neuropathy peripheral—Docetaxel—melanoma	0.000367	0.00132	CcSEcCtD
Acitretin—Dry mouth—Temozolomide—melanoma	0.000367	0.00131	CcSEcCtD
Acitretin—Stomatitis—Docetaxel—melanoma	0.000365	0.00131	CcSEcCtD
Acitretin—Jaundice—Docetaxel—melanoma	0.000365	0.00131	CcSEcCtD
Acitretin—Pain—Bleomycin—melanoma	0.000364	0.00131	CcSEcCtD
Acitretin—Conjunctivitis—Docetaxel—melanoma	0.000364	0.00131	CcSEcCtD
Acitretin—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000362	0.0013	CcSEcCtD
Acitretin—Oedema—Temozolomide—melanoma	0.000359	0.00129	CcSEcCtD
Acitretin—Infection—Temozolomide—melanoma	0.000357	0.00128	CcSEcCtD
Acitretin—Anorexia—Carmustine—melanoma	0.000354	0.00127	CcSEcCtD
Acitretin—Epistaxis—Docetaxel—melanoma	0.000353	0.00127	CcSEcCtD
Acitretin—Feeling abnormal—Bleomycin—melanoma	0.000351	0.00126	CcSEcCtD
Acitretin—Skin disorder—Temozolomide—melanoma	0.000349	0.00125	CcSEcCtD
Acitretin—Hyperhidrosis—Temozolomide—melanoma	0.000347	0.00124	CcSEcCtD
Acitretin—Decreased appetite—Dactinomycin—melanoma	0.000345	0.00124	CcSEcCtD
Acitretin—Fatigue—Dactinomycin—melanoma	0.000343	0.00123	CcSEcCtD
Acitretin—Anorexia—Temozolomide—melanoma	0.000343	0.00123	CcSEcCtD
Acitretin—Pain—Dactinomycin—melanoma	0.00034	0.00122	CcSEcCtD
Acitretin—Musculoskeletal discomfort—Carmustine—melanoma	0.000339	0.00121	CcSEcCtD
Acitretin—Urticaria—Bleomycin—melanoma	0.000338	0.00121	CcSEcCtD
Acitretin—Haemoglobin—Docetaxel—melanoma	0.000338	0.00121	CcSEcCtD
Acitretin—Rhinitis—Docetaxel—melanoma	0.000337	0.00121	CcSEcCtD
Acitretin—Body temperature increased—Bleomycin—melanoma	0.000337	0.00121	CcSEcCtD
Acitretin—Hepatitis—Docetaxel—melanoma	0.000336	0.00121	CcSEcCtD
Acitretin—Haemorrhage—Docetaxel—melanoma	0.000336	0.00121	CcSEcCtD
Acitretin—Insomnia—Carmustine—melanoma	0.000336	0.00121	CcSEcCtD
Acitretin—Hypoaesthesia—Docetaxel—melanoma	0.000335	0.0012	CcSEcCtD
Acitretin—Paraesthesia—Carmustine—melanoma	0.000334	0.0012	CcSEcCtD
Acitretin—Pharyngitis—Docetaxel—melanoma	0.000334	0.0012	CcSEcCtD
Acitretin—Oedema peripheral—Docetaxel—melanoma	0.000331	0.00119	CcSEcCtD
Acitretin—Somnolence—Carmustine—melanoma	0.000331	0.00118	CcSEcCtD
Acitretin—Feeling abnormal—Dactinomycin—melanoma	0.000327	0.00117	CcSEcCtD
Acitretin—Musculoskeletal discomfort—Temozolomide—melanoma	0.000327	0.00117	CcSEcCtD
Acitretin—Insomnia—Temozolomide—melanoma	0.000325	0.00116	CcSEcCtD
Acitretin—Gastrointestinal pain—Dactinomycin—melanoma	0.000325	0.00116	CcSEcCtD
Acitretin—Visual impairment—Docetaxel—melanoma	0.000324	0.00116	CcSEcCtD
Acitretin—Decreased appetite—Carmustine—melanoma	0.000323	0.00116	CcSEcCtD
Acitretin—Paraesthesia—Temozolomide—melanoma	0.000323	0.00116	CcSEcCtD
Acitretin—Gastrointestinal disorder—Carmustine—melanoma	0.000321	0.00115	CcSEcCtD
Acitretin—Somnolence—Temozolomide—melanoma	0.000319	0.00114	CcSEcCtD
Acitretin—Pain—Carmustine—melanoma	0.000318	0.00114	CcSEcCtD
Acitretin—Constipation—Carmustine—melanoma	0.000318	0.00114	CcSEcCtD
Acitretin—Dyspepsia—Temozolomide—melanoma	0.000316	0.00113	CcSEcCtD
Acitretin—Eye disorder—Docetaxel—melanoma	0.000314	0.00113	CcSEcCtD
Acitretin—Abdominal pain—Dactinomycin—melanoma	0.000314	0.00113	CcSEcCtD
Acitretin—Body temperature increased—Dactinomycin—melanoma	0.000314	0.00113	CcSEcCtD
Acitretin—Hypersensitivity—Bleomycin—melanoma	0.000314	0.00112	CcSEcCtD
Acitretin—Decreased appetite—Temozolomide—melanoma	0.000312	0.00112	CcSEcCtD
Acitretin—Flushing—Docetaxel—melanoma	0.000312	0.00112	CcSEcCtD
Acitretin—Gastrointestinal disorder—Temozolomide—melanoma	0.00031	0.00111	CcSEcCtD
Acitretin—Fatigue—Temozolomide—melanoma	0.00031	0.00111	CcSEcCtD
Acitretin—Pain—Temozolomide—melanoma	0.000307	0.0011	CcSEcCtD
Acitretin—Constipation—Temozolomide—melanoma	0.000307	0.0011	CcSEcCtD
Acitretin—Feeling abnormal—Carmustine—melanoma	0.000306	0.0011	CcSEcCtD
Acitretin—Asthenia—Bleomycin—melanoma	0.000306	0.0011	CcSEcCtD
Acitretin—Angiopathy—Docetaxel—melanoma	0.000305	0.00109	CcSEcCtD
Acitretin—Gastrointestinal pain—Carmustine—melanoma	0.000304	0.00109	CcSEcCtD
Acitretin—Immune system disorder—Docetaxel—melanoma	0.000304	0.00109	CcSEcCtD
Acitretin—Chills—Docetaxel—melanoma	0.000302	0.00108	CcSEcCtD
Acitretin—Pruritus—Bleomycin—melanoma	0.000301	0.00108	CcSEcCtD
Acitretin—Alopecia—Docetaxel—melanoma	0.000297	0.00107	CcSEcCtD
Acitretin—Feeling abnormal—Temozolomide—melanoma	0.000296	0.00106	CcSEcCtD
Acitretin—Abdominal pain—Carmustine—melanoma	0.000294	0.00105	CcSEcCtD
Acitretin—Body temperature increased—Carmustine—melanoma	0.000294	0.00105	CcSEcCtD
Acitretin—Gastrointestinal pain—Temozolomide—melanoma	0.000294	0.00105	CcSEcCtD
Acitretin—Erythema—Docetaxel—melanoma	0.000293	0.00105	CcSEcCtD
Acitretin—Hypersensitivity—Dactinomycin—melanoma	0.000293	0.00105	CcSEcCtD
Acitretin—Dysgeusia—Docetaxel—melanoma	0.000287	0.00103	CcSEcCtD
Acitretin—Urticaria—Temozolomide—melanoma	0.000286	0.00102	CcSEcCtD
Acitretin—Asthenia—Dactinomycin—melanoma	0.000285	0.00102	CcSEcCtD
Acitretin—Abdominal pain—Temozolomide—melanoma	0.000284	0.00102	CcSEcCtD
Acitretin—Body temperature increased—Temozolomide—melanoma	0.000284	0.00102	CcSEcCtD
Acitretin—Back pain—Docetaxel—melanoma	0.000283	0.00101	CcSEcCtD
Acitretin—Muscle spasms—Docetaxel—melanoma	0.000282	0.00101	CcSEcCtD
Acitretin—Hypersensitivity—Carmustine—melanoma	0.000274	0.000982	CcSEcCtD
Acitretin—Diarrhoea—Dactinomycin—melanoma	0.000272	0.000974	CcSEcCtD
Acitretin—Vomiting—Bleomycin—melanoma	0.000271	0.000971	CcSEcCtD
Acitretin—Rash—Bleomycin—melanoma	0.000269	0.000962	CcSEcCtD
Acitretin—Dermatitis—Bleomycin—melanoma	0.000268	0.000962	CcSEcCtD
Acitretin—Asthenia—Carmustine—melanoma	0.000267	0.000956	CcSEcCtD
Acitretin—Hypersensitivity—Temozolomide—melanoma	0.000265	0.000949	CcSEcCtD
Acitretin—Asthenia—Temozolomide—melanoma	0.000258	0.000924	CcSEcCtD
Acitretin—Cough—Docetaxel—melanoma	0.000256	0.000916	CcSEcCtD
Acitretin—Diarrhoea—Carmustine—melanoma	0.000254	0.000912	CcSEcCtD
Acitretin—Pruritus—Temozolomide—melanoma	0.000254	0.000911	CcSEcCtD
Acitretin—Nausea—Bleomycin—melanoma	0.000253	0.000907	CcSEcCtD
Acitretin—Vomiting—Dactinomycin—melanoma	0.000253	0.000905	CcSEcCtD
Acitretin—Rash—Dactinomycin—melanoma	0.000251	0.000898	CcSEcCtD
Acitretin—Chest pain—Docetaxel—melanoma	0.000249	0.000893	CcSEcCtD
Acitretin—Myalgia—Docetaxel—melanoma	0.000249	0.000893	CcSEcCtD
Acitretin—Arthralgia—Docetaxel—melanoma	0.000249	0.000893	CcSEcCtD
Acitretin—Dizziness—Carmustine—melanoma	0.000246	0.000881	CcSEcCtD
Acitretin—Diarrhoea—Temozolomide—melanoma	0.000246	0.000881	CcSEcCtD
Acitretin—Dry mouth—Docetaxel—melanoma	0.000244	0.000874	CcSEcCtD
Acitretin—Oedema—Docetaxel—melanoma	0.000239	0.000856	CcSEcCtD
Acitretin—Dizziness—Temozolomide—melanoma	0.000238	0.000852	CcSEcCtD
Acitretin—Infection—Docetaxel—melanoma	0.000237	0.000851	CcSEcCtD
Acitretin—Vomiting—Carmustine—melanoma	0.000236	0.000847	CcSEcCtD
Acitretin—Nausea—Dactinomycin—melanoma	0.000236	0.000846	CcSEcCtD
Acitretin—Rash—Carmustine—melanoma	0.000234	0.00084	CcSEcCtD
Acitretin—Dermatitis—Carmustine—melanoma	0.000234	0.000839	CcSEcCtD
Acitretin—Headache—Carmustine—melanoma	0.000233	0.000835	CcSEcCtD
Acitretin—Skin disorder—Docetaxel—melanoma	0.000232	0.000832	CcSEcCtD
Acitretin—Vomiting—Temozolomide—melanoma	0.000229	0.000819	CcSEcCtD
Acitretin—Anorexia—Docetaxel—melanoma	0.000228	0.000816	CcSEcCtD
Acitretin—Rash—Temozolomide—melanoma	0.000227	0.000812	CcSEcCtD
Acitretin—Dermatitis—Temozolomide—melanoma	0.000226	0.000811	CcSEcCtD
Acitretin—Headache—Temozolomide—melanoma	0.000225	0.000807	CcSEcCtD
Acitretin—Nausea—Carmustine—melanoma	0.000221	0.000791	CcSEcCtD
Acitretin—Musculoskeletal discomfort—Docetaxel—melanoma	0.000218	0.00078	CcSEcCtD
Acitretin—Insomnia—Docetaxel—melanoma	0.000216	0.000775	CcSEcCtD
Acitretin—Paraesthesia—Docetaxel—melanoma	0.000215	0.000769	CcSEcCtD
Acitretin—Nausea—Temozolomide—melanoma	0.000213	0.000765	CcSEcCtD
Acitretin—Somnolence—Docetaxel—melanoma	0.000212	0.000761	CcSEcCtD
Acitretin—Dyspepsia—Docetaxel—melanoma	0.00021	0.000754	CcSEcCtD
Acitretin—Decreased appetite—Docetaxel—melanoma	0.000208	0.000744	CcSEcCtD
Acitretin—Gastrointestinal disorder—Docetaxel—melanoma	0.000206	0.000739	CcSEcCtD
Acitretin—Fatigue—Docetaxel—melanoma	0.000206	0.000738	CcSEcCtD
Acitretin—Constipation—Docetaxel—melanoma	0.000204	0.000732	CcSEcCtD
Acitretin—Pain—Docetaxel—melanoma	0.000204	0.000732	CcSEcCtD
Acitretin—Feeling abnormal—Docetaxel—melanoma	0.000197	0.000706	CcSEcCtD
Acitretin—Gastrointestinal pain—Docetaxel—melanoma	0.000195	0.0007	CcSEcCtD
Acitretin—Body temperature increased—Docetaxel—melanoma	0.000189	0.000677	CcSEcCtD
Acitretin—Abdominal pain—Docetaxel—melanoma	0.000189	0.000677	CcSEcCtD
Acitretin—Hypersensitivity—Docetaxel—melanoma	0.000176	0.000631	CcSEcCtD
Acitretin—Asthenia—Docetaxel—melanoma	0.000171	0.000614	CcSEcCtD
Acitretin—Pruritus—Docetaxel—melanoma	0.000169	0.000606	CcSEcCtD
Acitretin—Diarrhoea—Docetaxel—melanoma	0.000164	0.000586	CcSEcCtD
Acitretin—Dizziness—Docetaxel—melanoma	0.000158	0.000566	CcSEcCtD
Acitretin—Vomiting—Docetaxel—melanoma	0.000152	0.000544	CcSEcCtD
Acitretin—Rash—Docetaxel—melanoma	0.000151	0.00054	CcSEcCtD
Acitretin—Dermatitis—Docetaxel—melanoma	0.000151	0.000539	CcSEcCtD
Acitretin—Headache—Docetaxel—melanoma	0.00015	0.000536	CcSEcCtD
Acitretin—Nausea—Docetaxel—melanoma	0.000142	0.000509	CcSEcCtD
Acitretin—RXRA—Developmental Biology—KDR—melanoma	4.85e-05	0.000181	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—PLA2G6—melanoma	4.8e-05	0.000179	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—PIK3CG—melanoma	4.78e-05	0.000179	CbGpPWpGaD
Acitretin—ALB—Hemostasis—RAC2—melanoma	4.78e-05	0.000178	CbGpPWpGaD
Acitretin—RXRG—Gene Expression—NOTCH1—melanoma	4.77e-05	0.000178	CbGpPWpGaD
Acitretin—RBP1—Disease—CTNNB1—melanoma	4.76e-05	0.000178	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—MET—melanoma	4.74e-05	0.000177	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—CDK4—melanoma	4.74e-05	0.000177	CbGpPWpGaD
Acitretin—ALB—Hemostasis—VEGFC—melanoma	4.7e-05	0.000176	CbGpPWpGaD
Acitretin—RXRA—Metabolism—PLA2G6—melanoma	4.69e-05	0.000175	CbGpPWpGaD
Acitretin—RARB—Gene Expression—NOTCH1—melanoma	4.68e-05	0.000175	CbGpPWpGaD
Acitretin—RBP1—Disease—CDKN1A—melanoma	4.65e-05	0.000174	CbGpPWpGaD
Acitretin—RBP1—Disease—PTEN—melanoma	4.64e-05	0.000173	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—PPARG—melanoma	4.62e-05	0.000172	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—BRAF—melanoma	4.61e-05	0.000172	CbGpPWpGaD
Acitretin—ALB—Folate Metabolism—TP53—melanoma	4.61e-05	0.000172	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—RAC1—melanoma	4.59e-05	0.000171	CbGpPWpGaD
Acitretin—RXRA—Generic Transcription Pathway—PPARG—melanoma	4.58e-05	0.000171	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—NOTCH1—melanoma	4.57e-05	0.000171	CbGpPWpGaD
Acitretin—ALB—Metabolism—HS3ST5—melanoma	4.52e-05	0.000169	CbGpPWpGaD
Acitretin—RXRG—Gene Expression—PPARG—melanoma	4.5e-05	0.000168	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—IGF1—melanoma	4.49e-05	0.000168	CbGpPWpGaD
Acitretin—RXRB—Gene Expression—NOTCH1—melanoma	4.48e-05	0.000167	CbGpPWpGaD
Acitretin—RARA—Gene Expression—NOTCH1—melanoma	4.48e-05	0.000167	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	4.46e-05	0.000167	CbGpPWpGaD
Acitretin—RARB—Gene Expression—PPARG—melanoma	4.41e-05	0.000165	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—MAP2K1—melanoma	4.34e-05	0.000162	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—TP53—melanoma	4.32e-05	0.000161	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—PIK3CD—melanoma	4.31e-05	0.000161	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—PPARG—melanoma	4.31e-05	0.000161	CbGpPWpGaD
Acitretin—RXRB—Gene Expression—PPARG—melanoma	4.23e-05	0.000158	CbGpPWpGaD
Acitretin—RARA—Gene Expression—PPARG—melanoma	4.23e-05	0.000158	CbGpPWpGaD
Acitretin—ALB—Folate Metabolism—IL6—melanoma	4.22e-05	0.000157	CbGpPWpGaD
Acitretin—RXRA—Metabolism—VCAN—melanoma	4.21e-05	0.000157	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—PIK3CD—melanoma	4.21e-05	0.000157	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—ALB—melanoma	4.15e-05	0.000155	CbGpPWpGaD
Acitretin—ALB—Selenium Micronutrient Network—TNF—melanoma	4.15e-05	0.000155	CbGpPWpGaD
Acitretin—RBP1—Disease—STAT3—melanoma	4.15e-05	0.000155	CbGpPWpGaD
Acitretin—RBP1—Disease—NRAS—melanoma	4.14e-05	0.000155	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—FGF2—melanoma	4.13e-05	0.000154	CbGpPWpGaD
Acitretin—ALB—Hemostasis—SPARC—melanoma	4.13e-05	0.000154	CbGpPWpGaD
Acitretin—ALB—Hemostasis—F2R—melanoma	4.13e-05	0.000154	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—HDAC2—melanoma	4.06e-05	0.000152	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—FN1—melanoma	4.05e-05	0.000151	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	3.99e-05	0.000149	CbGpPWpGaD
Acitretin—RBP1—Disease—MAPK3—melanoma	3.96e-05	0.000148	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—MMP2—melanoma	3.96e-05	0.000148	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—MAP2K1—melanoma	3.95e-05	0.000148	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—PIK3CG—melanoma	3.88e-05	0.000145	CbGpPWpGaD
Acitretin—ALB—Hemostasis—HSPA5—melanoma	3.86e-05	0.000144	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—MDM2—melanoma	3.86e-05	0.000144	CbGpPWpGaD
Acitretin—RBP1—Disease—MYC—melanoma	3.86e-05	0.000144	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—PPARG—melanoma	3.85e-05	0.000144	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—EGF—melanoma	3.83e-05	0.000143	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—ERBB2—melanoma	3.81e-05	0.000142	CbGpPWpGaD
Acitretin—ALB—Hemostasis—GAB2—melanoma	3.78e-05	0.000141	CbGpPWpGaD
Acitretin—ALB—Hemostasis—GNA11—melanoma	3.78e-05	0.000141	CbGpPWpGaD
Acitretin—RBP1—Disease—MAPK1—melanoma	3.77e-05	0.000141	CbGpPWpGaD
Acitretin—RBP1—Disease—EGFR—melanoma	3.77e-05	0.000141	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—PIK3CB—melanoma	3.76e-05	0.00014	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—FGF2—melanoma	3.76e-05	0.00014	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—PIK3CB—melanoma	3.67e-05	0.000137	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	3.64e-05	0.000136	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	3.64e-05	0.000136	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—PTGS2—melanoma	3.63e-05	0.000136	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—CXCL8—melanoma	3.61e-05	0.000135	CbGpPWpGaD
Acitretin—RBP1—Disease—KRAS—melanoma	3.56e-05	0.000133	CbGpPWpGaD
Acitretin—RXRA—Metabolism—CYP17A1—melanoma	3.56e-05	0.000133	CbGpPWpGaD
Acitretin—ALB—Hemostasis—HDAC2—melanoma	3.55e-05	0.000133	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—IGF1—melanoma	3.55e-05	0.000133	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—CDKN1B—melanoma	3.53e-05	0.000132	CbGpPWpGaD
Acitretin—ALB—Hemostasis—GNAQ—melanoma	3.51e-05	0.000131	CbGpPWpGaD
Acitretin—ALB—Hemostasis—ITGA4—melanoma	3.51e-05	0.000131	CbGpPWpGaD
Acitretin—ALB—Hemostasis—CD44—melanoma	3.51e-05	0.000131	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	3.51e-05	0.000131	CbGpPWpGaD
Acitretin—ALB—Hemostasis—IFNB1—melanoma	3.49e-05	0.00013	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—ERBB2—melanoma	3.47e-05	0.00013	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—ALB—melanoma	3.46e-05	0.000129	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—CASP3—melanoma	3.46e-05	0.000129	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—IL2—melanoma	3.45e-05	0.000129	CbGpPWpGaD
Acitretin—ALB—Metabolism—PLCB4—melanoma	3.43e-05	0.000128	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—PIK3CD—melanoma	3.41e-05	0.000127	CbGpPWpGaD
Acitretin—ALB—Hemostasis—IFNA1—melanoma	3.4e-05	0.000127	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—CCND1—melanoma	3.37e-05	0.000126	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—FASN—melanoma	3.36e-05	0.000126	CbGpPWpGaD
Acitretin—RXRA—Metabolism—GNA11—melanoma	3.36e-05	0.000125	CbGpPWpGaD
Acitretin—ALB—Selenium Micronutrient Network—IL6—melanoma	3.35e-05	0.000125	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—CTNNB1—melanoma	3.33e-05	0.000124	CbGpPWpGaD
Acitretin—ALB—Hemostasis—SYK—melanoma	3.3e-05	0.000123	CbGpPWpGaD
Acitretin—RXRA—Transmembrane transport of small molecules—ALB—melanoma	3.29e-05	0.000123	CbGpPWpGaD
Acitretin—RXRA—Metabolism—FASN—melanoma	3.29e-05	0.000123	CbGpPWpGaD
Acitretin—RBP1—Disease—PIK3CA—melanoma	3.27e-05	0.000122	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—MMP9—melanoma	3.27e-05	0.000122	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—CDKN1A—melanoma	3.26e-05	0.000122	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—PTEN—melanoma	3.25e-05	0.000121	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—CDKN2B—melanoma	3.24e-05	0.000121	CbGpPWpGaD
Acitretin—ALB—Hemostasis—ITGAV—melanoma	3.24e-05	0.000121	CbGpPWpGaD
Acitretin—ALB—Hemostasis—AKT3—melanoma	3.24e-05	0.000121	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—NFKB1—melanoma	3.23e-05	0.000121	CbGpPWpGaD
Acitretin—RXRA—Metabolism—SLC5A5—melanoma	3.23e-05	0.000121	CbGpPWpGaD
Acitretin—ALB—Metabolism—PIP4K2A—melanoma	3.22e-05	0.00012	CbGpPWpGaD
Acitretin—ALB—Metabolism—SLC6A11—melanoma	3.22e-05	0.00012	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—PTEN—melanoma	3.17e-05	0.000118	CbGpPWpGaD
Acitretin—ALB—Hemostasis—IFNA2—melanoma	3.16e-05	0.000118	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—VDR—melanoma	3.16e-05	0.000118	CbGpPWpGaD
Acitretin—ALB—Transmembrane transport of small molecules—SLC5A5—melanoma	3.15e-05	0.000118	CbGpPWpGaD
Acitretin—ALB—Metabolism—MTAP—melanoma	3.14e-05	0.000117	CbGpPWpGaD
Acitretin—RXRA—Metabolism—CD44—melanoma	3.12e-05	0.000117	CbGpPWpGaD
Acitretin—RXRA—Metabolism—GNAQ—melanoma	3.12e-05	0.000117	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	3.06e-05	0.000114	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	3.06e-05	0.000114	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—CTNNB1—melanoma	3.03e-05	0.000113	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—PTGS2—melanoma	3.03e-05	0.000113	CbGpPWpGaD
Acitretin—RBP1—Disease—HRAS—melanoma	3.03e-05	0.000113	CbGpPWpGaD
Acitretin—RXRA—Metabolism—CYP1B1—melanoma	2.99e-05	0.000112	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—MMP9—melanoma	2.97e-05	0.000111	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—PIK3CB—melanoma	2.97e-05	0.000111	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—NFKB1—melanoma	2.94e-05	0.00011	CbGpPWpGaD
Acitretin—ALB—Hemostasis—ITGB1—melanoma	2.94e-05	0.00011	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—VEGFA—melanoma	2.93e-05	0.00011	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—PRKCA—melanoma	2.92e-05	0.000109	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—STAT3—melanoma	2.91e-05	0.000109	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—NRAS—melanoma	2.9e-05	0.000108	CbGpPWpGaD
Acitretin—RBP1—Disease—IL6—melanoma	2.9e-05	0.000108	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—ERCC2—melanoma	2.89e-05	0.000108	CbGpPWpGaD
Acitretin—RARG—Gene Expression—MAPK3—melanoma	2.88e-05	0.000108	CbGpPWpGaD
Acitretin—RARG—Gene Expression—MYC—melanoma	2.8e-05	0.000105	CbGpPWpGaD
Acitretin—ALB—Metabolism—PHGDH—melanoma	2.79e-05	0.000104	CbGpPWpGaD
Acitretin—ALB—Metabolism—LUM—melanoma	2.79e-05	0.000104	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—MAPK3—melanoma	2.78e-05	0.000104	CbGpPWpGaD
Acitretin—ALB—Metabolism—HPSE—melanoma	2.74e-05	0.000102	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—IL2—melanoma	2.73e-05	0.000102	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—MYC—melanoma	2.7e-05	0.000101	CbGpPWpGaD
Acitretin—ALB—Hemostasis—HGF—melanoma	2.69e-05	0.000101	CbGpPWpGaD
Acitretin—ALB—Metabolism—CUBN—melanoma	2.69e-05	0.0001	CbGpPWpGaD
Acitretin—RBP1—Disease—AKT1—melanoma	2.67e-05	9.99e-05	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—VEGFA—melanoma	2.67e-05	9.98e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—CSF2—melanoma	2.66e-05	9.94e-05	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—STAT3—melanoma	2.64e-05	9.88e-05	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—MAPK1—melanoma	2.64e-05	9.86e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—PTEN—melanoma	2.64e-05	9.86e-05	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—EGFR—melanoma	2.64e-05	9.86e-05	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—NRAS—melanoma	2.64e-05	9.85e-05	CbGpPWpGaD
Acitretin—RXRG—Gene Expression—MAPK3—melanoma	2.64e-05	9.85e-05	CbGpPWpGaD
Acitretin—RXRA—Generic Transcription Pathway—MYC—melanoma	2.61e-05	9.75e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—SDHD—melanoma	2.6e-05	9.7e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—BSG—melanoma	2.6e-05	9.7e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—CSPG4—melanoma	2.6e-05	9.7e-05	CbGpPWpGaD
Acitretin—RARB—Gene Expression—MAPK3—melanoma	2.59e-05	9.66e-05	CbGpPWpGaD
Acitretin—RXRG—Gene Expression—MYC—melanoma	2.57e-05	9.58e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—ITGB3—melanoma	2.55e-05	9.53e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—PRKCA—melanoma	2.55e-05	9.53e-05	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—MAPK3—melanoma	2.53e-05	9.44e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—GPAM—melanoma	2.52e-05	9.4e-05	CbGpPWpGaD
Acitretin—RARB—Gene Expression—MYC—melanoma	2.52e-05	9.4e-05	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—KRAS—melanoma	2.49e-05	9.32e-05	CbGpPWpGaD
Acitretin—RXRB—Gene Expression—MAPK3—melanoma	2.48e-05	9.26e-05	CbGpPWpGaD
Acitretin—RARA—Gene Expression—MAPK3—melanoma	2.48e-05	9.26e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—ABCB1—melanoma	2.46e-05	9.2e-05	CbGpPWpGaD
Acitretin—RARA—Gene Expression—MYC—melanoma	2.41e-05	9.01e-05	CbGpPWpGaD
Acitretin—RXRB—Gene Expression—MYC—melanoma	2.41e-05	9.01e-05	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—MAPK1—melanoma	2.4e-05	8.98e-05	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—EGFR—melanoma	2.4e-05	8.98e-05	CbGpPWpGaD
Acitretin—ALB—Transmembrane transport of small molecules—ABCB1—melanoma	2.4e-05	8.96e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—RAC1—melanoma	2.37e-05	8.83e-05	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—NOTCH1—melanoma	2.34e-05	8.72e-05	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—VEGFA—melanoma	2.32e-05	8.66e-05	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—PIK3CA—melanoma	2.29e-05	8.56e-05	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—TNF—melanoma	2.29e-05	8.55e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—MMP1—melanoma	2.29e-05	8.55e-05	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—KRAS—melanoma	2.27e-05	8.48e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—PRKCA—melanoma	2.27e-05	8.47e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—ERCC2—melanoma	2.25e-05	8.4e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—CDK2—melanoma	2.25e-05	8.39e-05	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—PIK3CA—melanoma	2.23e-05	8.34e-05	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—TP53—melanoma	2.22e-05	8.28e-05	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—PPARG—melanoma	2.2e-05	8.23e-05	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—MAPK3—melanoma	2.19e-05	8.19e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—PLA2G6—melanoma	2.14e-05	7.99e-05	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—HRAS—melanoma	2.12e-05	7.92e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—FN1—melanoma	2.09e-05	7.8e-05	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—MAPK1—melanoma	2.09e-05	7.79e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—NOS2—melanoma	2.06e-05	7.71e-05	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—IL6—melanoma	2.03e-05	7.58e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—PIK3CG—melanoma	2e-05	7.46e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—EGF—melanoma	1.98e-05	7.38e-05	CbGpPWpGaD
Acitretin—RARG—Gene Expression—AKT1—melanoma	1.95e-05	7.26e-05	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—HRAS—melanoma	1.93e-05	7.21e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—VCAN—melanoma	1.92e-05	7.18e-05	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—AKT1—melanoma	1.87e-05	6.99e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.86e-05	6.96e-05	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—IL6—melanoma	1.85e-05	6.9e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—IGF1—melanoma	1.83e-05	6.83e-05	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—AKT1—melanoma	1.83e-05	6.82e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	1.82e-05	6.79e-05	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—PIK3CA—melanoma	1.81e-05	6.76e-05	CbGpPWpGaD
Acitretin—RXRG—Gene Expression—AKT1—melanoma	1.78e-05	6.64e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—PIK3CG—melanoma	1.78e-05	6.63e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—PIK3CD—melanoma	1.76e-05	6.56e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—PPARG—melanoma	1.76e-05	6.56e-05	CbGpPWpGaD
Acitretin—RARB—Gene Expression—AKT1—melanoma	1.74e-05	6.52e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—PPARG—melanoma	1.71e-05	6.4e-05	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—AKT1—melanoma	1.7e-05	6.36e-05	CbGpPWpGaD
Acitretin—RARA—Gene Expression—AKT1—melanoma	1.67e-05	6.25e-05	CbGpPWpGaD
Acitretin—RXRB—Gene Expression—AKT1—melanoma	1.67e-05	6.25e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—CYP17A1—melanoma	1.62e-05	6.06e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	1.6e-05	5.97e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—PIK3CD—melanoma	1.56e-05	5.83e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—ALB—melanoma	1.54e-05	5.76e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—GNA11—melanoma	1.53e-05	5.72e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—PIK3CB—melanoma	1.53e-05	5.72e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—FASN—melanoma	1.5e-05	5.6e-05	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—AKT1—melanoma	1.48e-05	5.52e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—SLC5A5—melanoma	1.47e-05	5.5e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—GNAQ—melanoma	1.42e-05	5.32e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—CD44—melanoma	1.42e-05	5.32e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—IL2—melanoma	1.41e-05	5.25e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1.39e-05	5.21e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—PTGS2—melanoma	1.38e-05	5.16e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—CYP1B1—melanoma	1.36e-05	5.1e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—PIK3CB—melanoma	1.36e-05	5.08e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—PTGS2—melanoma	1.35e-05	5.04e-05	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—MAPK3—melanoma	1.29e-05	4.83e-05	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—MYC—melanoma	1.26e-05	4.69e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.2e-05	4.5e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—VEGFA—melanoma	1.2e-05	4.46e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—NRAS—melanoma	1.18e-05	4.41e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—PTEN—melanoma	1.18e-05	4.39e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—MAPK3—melanoma	1.13e-05	4.22e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—ABCB1—melanoma	1.12e-05	4.2e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—MAPK1—melanoma	1.08e-05	4.02e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—PRKCA—melanoma	1.03e-05	3.86e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—ERCC2—melanoma	1.03e-05	3.83e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—KRAS—melanoma	1.02e-05	3.79e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—PIK3CA—melanoma	9.33e-06	3.49e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—TP53—melanoma	9.03e-06	3.37e-05	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—AKT1—melanoma	8.72e-06	3.26e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—HRAS—melanoma	8.64e-06	3.23e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	8.5e-06	3.17e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—PIK3CA—melanoma	8.3e-06	3.1e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—PIK3CG—melanoma	8.1e-06	3.03e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—PPARG—melanoma	7.82e-06	2.92e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—AKT1—melanoma	7.63e-06	2.85e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—PIK3CD—melanoma	7.12e-06	2.66e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—AKT1—melanoma	6.78e-06	2.53e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—PIK3CB—melanoma	6.21e-06	2.32e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—PTGS2—melanoma	6.15e-06	2.3e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—PTEN—melanoma	5.36e-06	2e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—PIK3CA—melanoma	3.78e-06	1.41e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—AKT1—melanoma	3.09e-06	1.15e-05	CbGpPWpGaD
